Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin, XELOX, and Anti-PD-1 for Locally Advanced pMMR Colorectal Cancer
NCT07365592Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in colorectal cancer (CRC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Apr 2026; status: recruiting.
02
Drugs
sitagliptin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07365592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07365592.